Subgroup analysis in obstetrics clinical trials
- 31 August 2007
- journal article
- review article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 197 (2) , 119-122
- https://doi.org/10.1016/j.ajog.2007.02.030
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- The Challenge of Subgroup Analyses — Reporting without DistortingNew England Journal of Medicine, 2006
- Does Progesterone Treatment Influence Risk Factors for Recurrent Preterm Delivery?Obstetrics & Gynecology, 2005
- Subgroup analysis in randomised controlled trials: importance, indications, and interpretationThe Lancet, 2005
- Prevention of Recurrent Preterm Delivery by 17 Alpha-Hydroxyprogesterone CaproateNew England Journal of Medicine, 2003
- ISSUES RELATED TO SUBGROUP ANALYSIS IN CLINICAL TRIALSJournal of Biopharmaceutical Statistics, 2002
- Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negativesHealth Technology Assessment, 2001
- Metronidazole to Prevent Preterm Delivery in Pregnant Women with Asymptomatic Bacterial VaginosisNew England Journal of Medicine, 2000
- Antenatal corticosteroid therapy: A meta-analysis of the randomized trials, 1972 to 1994American Journal of Obstetrics and Gynecology, 1995
- Prevention of Preeclampsia with Low-Dose Aspirin in Healthy, Nulliparous Pregnant WomenNew England Journal of Medicine, 1993
- Effect of antenatal dexamethasone administration on the prevention of respiratory distress syndrome**See Editorial Comment following this article.American Journal of Obstetrics and Gynecology, 1981